Exelixis reported $0 in Loan Capital for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.28M 0.28M
AstraZeneca AZN:LN 28888M 51M
Bayer BAYN:GR € 36481M 493M
Cytokinetics CYTK:US $ 197.08M 54.24M
Eisai 4523:JP Y 49924M 5M
Genmab GEN:DC 356M 7M
IONIS PHARMACEUT IONS:US $ 1247M 5.31M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 24523M 192M